[Translation] A multicenter, randomized, open-label, parallel-controlled phase III clinical study comparing the efficacy and safety of semaglutide injection and Novota® in patients with type 2 diabetes mellitus poorly controlled after metformin treatment
在二甲双胍治疗后血糖控制不佳的2型糖尿病患者中论证试验药物司美格鲁肽注射液与对照药物司美格鲁肽注射液(诺和泰®)在治疗32周后血糖控制的等效性。
[Translation] To demonstrate the equivalence of the experimental drug semaglutide injection and the control drug semaglutide injection (Novota®) in blood glucose control after 32 weeks of treatment in type 2 diabetic patients with poor blood glucose control after metformin treatment sex.